Alexander Weymann
Overview
Explore the profile of Alexander Weymann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
316
Citations
1957
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa C, Arjomandi Rad A, Yu Y, Mayooran N, Xanthopoulos A, Koulouroudias M, et al.
Artif Organs
. 2025 Mar;
PMID: 40087871
Background: Frailty, marked by increased vulnerability and reduced physiological reserve, is common in end-stage heart failure patients. Continuous flow left ventricular assist devices (LVADs) have improved outcomes, but the impact...
2.
Darbaidze Z, Schmack B, Dogan G, Merzah A, Gabriel M, Gorler A, et al.
Artif Organs
. 2025 Feb;
PMID: 40008930
Introduction: Terminal heart failure is often associated with end-stage kidney disease. Due to advantages concerning patient independence, peritoneal dialysis (PD) is an alternative to conventional hemodialysis treatment. As left ventricular...
3.
Poyanmehr R, Hanke J, Boethig D, Merzah A, Karsten J, Frank P, et al.
Circ Heart Fail
. 2025 Jan;
18(2):e012154.
PMID: 39831321
Background: Consensus regarding on-support evaluation and weaning concepts from Impella 5.5 support is scarce. The derived left ventricular end-diastolic pressure (dLVEDP), estimated by device algorithms, is a rarely reported tool...
4.
Schmack L, Ali-Hasan-Al-Saegh S, Weymann A, Pizanis N, Akhyari P, Zubarevich A, et al.
Medicina (Kaunas)
. 2025 Jan;
60(12.
PMID: 39768841
The use of temporary left ventricular assist devices (tLVADs) for patients suffering from cardiogenic shock (CS) is becoming more common. This study examines the indications and outcomes of microaxial flow...
5.
Knigge S, Dogan G, Deniz E, Hanke J, Merzah A, Berliner D, et al.
Artif Organs
. 2024 Dec;
49(3):525-531.
PMID: 39704302
Background: The study assesses the feasibility of the DuoCor BiVAS, a novel biventricular assist system integrating magnetic levitation technology. Methods: In an acute large animal model involving five sheep, each...
6.
Kruszona S, Aburahma K, Wand P, de Manna N, Avsar M, Bobylev D, et al.
Eur J Cardiothorac Surg
. 2024 Dec;
66(6).
PMID: 39626308
Objectives: Severe pulmonary hypertension (PH) is the leading indication for a lung transplant in younger patients. Despite the availability of validated risk scores, their influence on lung allocation has been...
7.
Al-Hasan-Al-Saegh S, Takemoto S, Benenati S, Shafiei S, Yavuz S, Galli M, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39598121
: The optimal choice of cardioplegia solution in minimally invasive cardiac surgeries (MICS) remains debated, as prolonged myocardial protection is essential to avoid interruptions to the surgical flow, which can...
8.
Ali-Hasan-Al-Saegh S, Helms F, Aburahma K, Takemoto S, De Manna N, Amanov L, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518495
Over the past two decades, significant advancements in mitral valve surgery have focused on minimally invasive techniques. Some surgeons consider obesity as a relative contraindication for minimally invasive mitral valve...
9.
De Manna N, Helms F, Deniz E, Kaireit T, Abu-Fares O, Schmack B, et al.
Front Cardiovasc Med
. 2024 Oct;
11:1429287.
PMID: 39390989
Background: Acute Type A aortic dissection (ATAAD) with supra-aortic branch (SAB) malperfusion remains a formidable clinical challenge, often resulting in high mortality and complex treatment dilemmas. The introduction of the...
10.
Deniz E, Bobylev D, Kruger H, Salman J, Zubarevich A, Martens A, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39336832
Complications after aortic coarctation repair are associated with high mortality and require surgical or endovascular reintervention. For patients unsuitable for endovascular therapies, reoperation remains the only therapeutic option. However, surgical...